Citadel Advisors’s Heliogen, Inc. HLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,034
Closed -$26K 15436
2023
Q2
$26K Sell
3,034
-3
-0.1% -$27 ﹤0.01% 12503
2023
Q1
$25.5K Buy
3,037
+1,486
+96% +$22.6K ﹤0.01% 12870
2022
Q4
$37.9K Sell
1,551
-423
-21% -$19.1K ﹤0.01% 12478
2022
Q3
$129K Sell
1,974
-786
-28% -$61.3K ﹤0.01% 10866
2022
Q2
$204K Buy
2,760
+206
+8% +$26.8K ﹤0.01% 10656
2022
Q1
$470K Sell
2,554
-5,272
-67% -$962K ﹤0.01% 9543
2021
Q4
$4.25M Buy
+7,826
New +$2.74M ﹤0.01% 4624

Other funds holding HLGN

Citadel Advisors's HLGN Position: Q2 2023 in Review

Citadel Advisors sold out of Heliogen, Inc. (HLGN) in Q2 2023, closing a stake of 18 shares — an estimated $165 sold.

Citadel Advisors first reported a position in HLGN in Q4 2021 and held it in 5 quarters. The position peaked at $514K in Q4 2021. 71 funds tracked by Wall St. Rank hold HLGN as of Q2 2023.

  • Citadel Advisors reported no remaining Heliogen, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 18 Heliogen, Inc. shares in Q2 2023, an estimated $165.
  • Citadel Advisors first reported a position in Heliogen, Inc. in Q4 2021 and held it in 5 quarters.
  • Citadel Advisors's Heliogen, Inc. position peaked at $514K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.